From Glutamatergic Dysfunction to Cognitive Impairment: Boundaries in the Therapeutic of the Schizophrenia

Publisher: Bentham Science Publishers

E-ISSN: 1873-4316|13|8|1543-1548

ISSN: 1389-2010

Source: Current Pharmaceutical Biotechnology, Vol.13, Iss.8, 2012-06, pp. : 1543-1548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract